Stefanini Group and Scopism Survey Reveals Rapid AI Adoption, Identifies Key Global Trends Shaping Service Integration and Management (SIAM)
3.11.2025 15:42:00 CET | Business Wire | Press Release
Stefanini Group, a global tech consulting company with strong expertise in digital transformation and artificial intelligence solutions, and Scopism, a global leader in Service Integration and Management (SIAM) best practices, today announced the release of the Global SIAM Survey 2025 White Paper. The eighth annual report, sponsored by Stefanini, was launched and presented by a panel at the Scopism Service North Conference in Manchester, UK, and provides unrivalled insights into SIAM adoption, maturity, and emerging trends worldwide.
The survey continues to track the impact of artificial intelligence (AI) on SIAM models. Results show that while reported use of AI in SIAM models overall has remained stable, AI adoption within specific areas, such as incident management, has increased significantly, with 85% of organizations now reporting AI use. At the same time, respondents noted that challenges around integration (74% of respondents), cost (64%) and data privacy (50%) remain major considerations.
This year’s white paper also explores:
- Expected benefits, challenges and timelines for organizations planning to adopt SIAM.
- Adoption journeys, structures, benefits achieved, and lessons learned among organizations already using SIAM.
- Insights into client expectations, challenges and the skills required to deliver SIAM successfully from SIAM consultancy and solution providers.
The 2025 survey paints a detailed picture of the evolving SIAM sector by gathering responses from 232 participants from a diverse array of industries and organizations across 34 countries.
Stefanini sponsored the eighth edition of the Global SIAM Survey, which continues to provide unrivalled insights into SIAM adoption, maturity and emerging trends worldwide.
“At Stefanini, we believe SIAM is critical to enabling organizations to deliver consistent, integrated services in complex multi-supplier environments,” said Farlei Kothe, CEO at Stefanini North America, EMEA and Asia Pacific. “The 2025 survey highlights how AI and automation are reshaping SIAM adoption, but also reminds us that success requires strong governance and collaboration. We are proud to support the global SIAM community with insights that drive meaningful progress.”
“The Global SIAM Survey continues to evolve alongside the community it represents. This year’s results show both the growing maturity of SIAM practices and the real challenges organizations face in adopting new technologies such as AI,” said Claire Agutter, the founder and director of Scopism. “We are delighted to work with Stefanini to bring these insights to practitioners worldwide, helping them to learn from each other and advance their SIAM journeys.”
According to Claire, 2026 will see SIAM continue to evolve and mature. “SIAM practices will need to incorporate the growing adoption of experience management, and there will also be a much tighter focus on the return on investment for AI spend, looking at the value that AI and automation are delivering across the supplier ecosystem. We expect MSPs to respond to these trends with an increased focus on SIAM-related products and ‘SIAM as a service’ offerings. SIAM adoption will continue to grow around the globe, with North America experiencing rapid increases.”
The Global SIAM Survey 2025 White Paper is now available to download at: https://scopism.circle.so/c/global-siam-surveys-5de2c9/scopism-stefanini-group-global-siam-survey-2025.
###
About Stefanini Group
Stefanini is a Global Tech Consulting Company that offers a wide range of solutions with a co-creative approach and a constant focus on delivering results. The company supports organizations in their digital transformation journeys and in achieving operational excellence. With a portfolio fully powered by AI, the Stefanini Group brings together its broad offering across seven business units: Technology, Cyber, Data & Analytics, Financial Tech, Operations, Marketing, and Manufacturing.
About Scopism
Scopism is the home of best practices for service integration and management (SIAM). We support the SIAM community with events, advisory services, and up-to-date resources, including the SIAM Foundation and Professional Body of Knowledge. Through the Scopism SIAM Community, practitioners worldwide can connect, share experiences, and shape the future of SIAM. Learn more: www.scopism.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251103648912/en/
Contacts
Vanessa Morais
+1(248)688.1121
vanessa.morais@stefanini.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom